Digital x-ray developer Swissray International announced this month its plans to reorganize the company, although it declined to provide details of the restructuring. The company said restructuring was necessary as the firm moves from a development phase
Digital x-ray developer Swissray International announced this month its plans to reorganize the company, although it declined to provide details of the restructuring. The company said restructuring was necessary as the firm moves from a development phase into a product marketing phase. Swissray's AddOn-Multi-System received 510(k) clearance in December (SCAN 1/21/98). The New York City-based firm also said that it plans to immediately enter negotiations with a group of investors concerning a financing of the firm's short-term and medium-term capital needs.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.